Synonym
SEL120-34A; SEL 120-34A; SEL-120-34A; SEL12034A; SEL 12034A; SEL-12034A
IUPAC/Chemical Name
7,8-dibromo-9-methyl-2-(piperazin-1-yl)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline
InChi Key
FSBMCTDYWXIBLM-UHFFFAOYSA-N
InChi Code
InChI=1S/C15H18Br2N4/c1-9-11(16)12(17)10-3-2-6-21-14(10)13(9)19-15(21)20-7-4-18-5-8-20/h18H,2-8H2,1H3
SMILES Code
CC1=C2C3=C(CCCN3C(=N2)N4CCNCC4)C(=C1Br)Br
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
414.15
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Rzymski T, Mikula M, Żyłkiewicz E, Dreas A, Wiklik K, Gołas A, Wójcik K,
Masiejczyk M, Wróbel A, Dolata I, Kitlińska A, Statkiewicz M, Kuklinska U, Goryca
K, Sapała Ł, Grochowska A, Cabaj A, Szajewska-Skuta M, Gabor-Worwa E, Kucwaj K,
Białas A, Radzimierski A, Combik M, Woyciechowski J, Mikulski M, Windak R,
Ostrowski J, Brzózka K. SEL120-34A is a novel CDK8 inhibitor active in AML cells
with high levels of serine phosphorylation of STAT1 and STAT5 transactivation
domains. Oncotarget. 2017 May 16;8(20):33779-33795. doi:
10.18632/oncotarget.16810. PubMed PMID: 28422713; PubMed Central PMCID:
PMC5464911.
2: Kuang, Y., Golan, O., Preusse, K., Cain, B., Christensen, C. J., Salomone, J., ... & Gebelein, B. (2020). Enhancer architecture sensitizes cell specific responses to Notch gene dose via a bind and discard mechanism. Elife, 9, e53659.